A new month can be a good time to put fresh money to work.

If you have $10,000 ready to invest in July, there are some high-quality ASX shares that could be worth a closer look.

Here are three that stand out as long-term options.

Breville Group Ltd (ASX: BRG)

Breville could be an ASX share to consider in July.

The company has built a global business around premium kitchen appliances, with products across coffee machines, cooking, food preparation, and other household categories.

The attraction here is not just that Breville sells appliances. It is that the company has found a way to turn everyday household products into aspirational purchases.

A coffee machine can become part of a routine. A better oven, air fryer, or food processor can become part of how people cook at home. This gives Breville exposure to consumer habits that can last well beyond the initial purchase.

The company also has a long international growth runway. Its brand has already travelled successfully across key markets, but there is still room to build awareness, expand distribution, and launch more products over time.

ResMed Inc (ASX: RMD)

Another ASX share that could be worth buying in July is ResMed.

It operates in sleep apnoea treatment and connected respiratory care, helping patients manage breathing-related conditions through devices, masks, software, and ongoing support.

The company sits in an area of healthcare where demand is being supported by awareness, diagnosis, ageing populations, and the need for better long-term patient management.

One of ResMed’s strengths is that treatment does not usually end with the first device sale. Patients may need replacement masks, accessories, software support, and continued care over time. That creates a repeat revenue profile that can be attractive over the long term.

With a global market position and a large pool of untreated patients, ResMed could be a high-quality healthcare share to buy and hold.

Xero Ltd (ASX: XRO)

A third ASX share to look at is Xero. It provides cloud accounting software for small businesses, accountants, and bookkeepers.

Xero’s platform helps users manage invoicing, payroll, bank feeds, reporting, compliance, payments, and adviser workflows. That puts Xero close to the financial engine room of small businesses.

The company’s opportunity is bigger than accounting alone. As small businesses become more digital, they need tools that reduce admin, improve visibility, and connect them more easily with advisers, banks, and payment systems.

Xero already has a strong position in markets such as Australia, New Zealand, and the United Kingdom, while other international markets, such as the United States, provide room for longer-term growth.

In addition, artificial intelligence could become an important part of the platform over time by automating routine tasks and improving the usefulness of the software. This could give its annual recurring revenue a big boost over the next decade.

The post Where to invest $10,000 in ASX shares in July appeared first on The Motley Fool Australia.

More reading

• The Nasdaq just had its worst week in months. Here’s what that means for ASX tech stocks
• 3 reasons why the Xero share price is a buy in July
• Buy, hold, sell: Woodside, Xero, BHP shares
• ASX 200 retail shares outperform on growing hopes interest rates have peaked
• How to invest $500, $5,000, and $50,000 on the ASX

Motley Fool contributor James Mickleboro has positions in ResMed and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• Zip shares are flying again. Is this ASX 200 stock finally back in favour?
• ASX 200 rebounds as Middle East fears cool
• Why this ASX energy stock is jumping 8% after a brutal sell-off
• Life360 shares just jumped 11%. Here’s what’s driving the rally
• Buy, hold, sell: Wildcat Resources, NAB, Wisetech shares

Zip Co Ltd (ASX: ZIP) shares are pushing higher again on Monday as buyers return to the buy now, pay later (BNPL) stock.

At the time of writing, the Zip share price is up 8.33% to $3.12.

That extends a strong recent run for the ASX 200 stock. Zip shares are now up around 40% over the past month, although they remain below their 52-week high of $4.93.

More than 18 million shares had changed hands by early afternoon, with Zip trading between $2.93 and $3.14.

Here’s what appears to be helping sentiment today.

Profit momentum is doing the work

The main reason buyers are returning is that Zip is no longer being judged only on transaction growth.

According to Zip’s latest quarterly update, total transaction volume (TTV) rose 22.4% to $4 billion in the third quarter of FY26.

Total income increased 20.2% to $335.2 million.

More importantly, record cash EBTDA rose 41.5% to $65.1 million, while the operating margin expanded to 19.4%.

That was enough for management to upgrade FY26 group cash EBTDA guidance to at least $260 million.

The US business is still doing much of the heavy lifting though.

Zip said US transaction volume and revenue both grew more than 43% in US dollar terms, while US active customers increased 9%.

Bad debts are still being watched

While the growth is certainly positive, bad debts still remain one of the key risks.

Group net bad debts rose to 1.93% of transaction volume in the third quarter, up from 1.64% a year earlier.

However, Zip advised US net bad debts were steady at 1.86% of transaction volume and are expected to fall below 1.75% in the fourth quarter.

Nonetheless, the next update will be very important. Zip has the profit momentum, but it still needs to show that its bad debts are under control.

Brokers still see some upside

The broker backdrop also looks supportive.

Recent price targets include $3.10 from UBS, $3.40 from Macquarie, $3.80 from Jefferies, and $4.00 from Ord Minnett.

TradingView data also shows analysts have an average 12-month price target of $3.82 for Zip, with estimates ranging from $2.60 to $5.40.

At $3.82, the average target still sits above where Zip shares are trading today.

However, the stock has moved quickly.

The relative strength index (RSI) is sitting around 70, which points to strong momentum. But after a 40% monthly gain, it also tells us that Zip may be running a little hot in the short-term.

Can the rally keep going?

Zip is in a much better position than it was a few months ago.

The company is growing, earnings are improving, brokers remain positive, and the share buyback is still running in the background.

Zip announced an on-market buyback of up to $50 million in February, with regular buyback updates continuing through June.

However, the stock has already moved quickly over the past month, so the next update will need to excite the market.

The post Zip shares are flying again. Is this ASX 200 stock finally back in favour? appeared first on The Motley Fool Australia.

More reading

• Why I think Life360 and Zip shares are strong buys
• Why I’d buy CSL and Zip shares before they recover
• If I’d invested $7,000 in Zip shares 3 months ago, guess what I’d have now!
• Up 96%: What on earth has happened to Zip shares?
• Could this ASX 200 share double by 2030?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Turaco Gold Ltd (ASX: TCG) has caught the eye of a few brokers recently, after it released a positive prefeasibility study for its Afema Gold Project in southeast Côte d’Ivoire.

This time, we’re having a look at what the team at Morgans is saying about the company and how much they think its shares are worth.

First, let’s look at the company’s project.

New mine to drive share price growth

Turaco earlier this month declared a maiden ore reserve of 1.91 million ounces of gold, which it says will sustain a mine producing more than 200,000 ounces of gold per year.

And in terms of the mine’s revenue generation, the company published figures for a range of gold prices, but at US$4,000 per ounce – close to the current spot price of US$4,071.84 – the mine would generate gross revenue of US$8.095 billion over its life of 10.3 years.

The project would also have a payback period of 10 months, or 17 months if the gold price was US$3,000 per ounce.

Turaco said there was the possibility of extensions to the mineral resources, with all deposits open at depth and along strike, and there were also “numerous” additional exploration targets.

The company has immediately started a definitive feasibility study, which will also include commencing detailed design and engineering.

On the exploration front, the company will be continuing drilling with between three and five rigs operating.

Turaco Managing Director Justin Tremain said regarding the study:

In just a little over 2 years since acquiring Afema, the Turaco team has not only delivered extraordinary JORC Resource growth to 4.65 million ounces but has now also delivered a detailed development study with a maiden JORC Probable Ore Reserve estimate of just under 2 million ounces of gold based on a conservative gold price of US$2,000/oz and an AISC of just over US$1,500/oz, all within a granted mining permit. This progress is unmatched. The Study is the culmination of an extensive body of work including over 100,000m of drilling, comprehensive metallurgical variability test work, geotechnical test work, process and mine design, costing and scheduling.

Mr Tremain said the company was aiming to finish the definitive feasibility study by the second quarter of calendar year 2027 and to commence early works to allow first gold production in 2029.

Shares still looking cheap

The team at Morgans likes the project, but has sharply downgraded its price target for the company in its recent note to clients.

The analysts said:

While the prefeasibility study reinforces our conviction in Afema, following the transition of coverage, we have updated our forecasts to reflect the study outcomes and revised our valuation methodology. We also revise our recommendation to speculative buy, reflecting our reassessment of sovereign risk, together with the increased funding and execution risks associated with TCG’s transition from explorer to developer.

Morgans has a price target of $1.18 on Turaco shares, compared to $2.19 previously.

Macquarie also recently published a research report on Turaco with a price target of $1 per share.

Turaco shares are currently valued at 47 cents. The company is valued at $506.2 million.

The post Want a 151% return? One broker thinks this ASX gold company could deliver appeared first on The Motley Fool Australia.

More reading

• 8 ASX shares with 30% to 220% upside ahead: Experts
• Macquarie says this ASX gold stock can return better than 80%

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is back in the green on Monday as investors take a slightly calmer view of the Middle East.

At the time of writing, the benchmark index is up 0.22% to 8,783 points.

It was a stronger move earlier in the day, with the ASX 200 rising as high as 8,822 points before giving back a large part of its morning gain.

The gains came after reports that the United States and Iran have agreed to pause recent attacks and return to talks over the Strait of Hormuz.

Oil prices are still higher, with crude trading around US$70.03 a barrel, up 1.16%.

US futures are also pointing higher, giving local investors a better lead after a choppy finish to last week.

Here are some of the ASX 200 shares helping keep the market in positive territory today.

Banks and healthcare shares lift the index

The big four banks are doing a fair bit of the work today.

Commonwealth Bank of Australia (ASX: CBA) shares are up 0.73% to $163.21, while National Australia Bank Ltd (ASX: NAB) shares are up 0.88% to $37.84.

Westpac Banking Corp (ASX: WBC) shares are also higher, rising 0.34% to $35.26, and ANZ Group Holdings Ltd (ASX: ANZ) shares are up 0.03% to $35.05.

Healthcare shares are giving the market another boost after a rough patch for parts of the sector.

CSL Ltd (ASX: CSL) shares are up 1.23% to $116.28, while Pro Medicus Ltd (ASX: PME) shares are 2.99% higher at $194.53.

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares are also trading higher, rising 1.60% to $32.075.

Aristocrat Leisure Ltd (ASX: ALL) is another large-cap name helping the index, with its shares up 3.19% to $60.56.

But there are still plenty of losers

Even with the ASX 200 higher, there are still some large-cap shares holding it back.

Transurban Group (ASX: TCL) shares are down 4.55% to $14.69, making it one of the bigger drags on the index today.

BHP Group Ltd (ASX: BHP) shares are down 0.09% to $58.94, while Rio Tinto Ltd (ASX: RIO) shares are down 1.20% to $171.55.

Northern Star Resources Ltd (ASX: NST) shares are also under pressure, falling 1.89% to $20.20.

On the other hand, Fortescue Ltd (ASX: FMG) shares are moving the other way, rising 1% to $19.26.

What investors are watching now

Today’s move is a welcome lift for the ASX 200, but the index is still up just 0.8% since the start of 2026.

The next test is whether the ASX 200 can hold onto its gain into the close.

If the banks and healthcare stocks keep pushing higher, the market should have a better chance of finishing in positive territory.

The post ASX 200 rebounds as Middle East fears cool appeared first on The Motley Fool Australia.

More reading

• What are ASX 200 futures?
• Atlas Arteria reacts to Dulles Greenway litigation outcome
• 5 things to watch on the ASX 200 on Monday
• If you want to use this strategy to top up your superannuation you have to act today
• Here is the average Australian superannuation balance at ages 45, 55, and 65

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Transurban Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool Australia has recommended BHP Group, CSL, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

My portfolio is heavily weighted towards ASX dividend shares that can provide a mixture of dividends and capital growth. I like both types of returns because I can become wealthier over time through a rising portfolio value, while experiencing larger dividend payouts and benefiting my bank account. That cash can be put towards more shares or life expenses.

The three ASX dividend shares I’m going to highlight are ones that have a track record of growing their payouts and I expect further growth in the coming years.

MFF Capital Investments Ltd (ASX: MFF)

MFF Capital is best known as a listed investment company (LIC), though it recently acquired a funds management business, giving it an operational element.

The ASX dividend share has a portfolio focused on strong, global businesses with great competitive advantages and have the potential to grow profit in the long-term. Its biggest positions are currently Alphabet, Amazon, Mastercard and Visa.

Its high-quality portfolio picks have led to the MFF portfolio delivering strong investment returns over the last five, 10 and 15 years. This has allowed the business to build an impressive profit reserve, allowing it to pay large and growing dividends.

The company’s regular annual dividend has increased each year since FY18 and it expects to grow its annual dividend in FY26 by 23.5% to 21 cents per share. That’s a current grossed-up dividend yield of 5.9%, including franking credits.

Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

Soul Patts is another impressive investment business that has been listed for more than 120 years.

The investment house has a portfolio spread across a variety of assets that are largely uncorrelated and can provide Soul Patts with defensive and diversified cash flow, which is what funds Soul Patts’ impressive and growing dividends.

The ASX dividend share’s portfolio includes investments across energy, resources, property, swimming schools, agriculture, water entitlements, electrification, credit, financial services, building products and plenty more.

How good are the dividends? It’s the reliability and consistent growth that attracted to me. Its regular annul payout has been hiked every year since 1998. That’s the longest record of consecutive dividend growth on the ASX.

It currently has a grossed-up dividend yield of 3.4%, including franking credits.

L1 Long Short Fund Ltd (ASX: LSF)

This business is another LIC in my portfolio. The ASX dividend share invests quite differently compared to a typical fund manager. It invests in both ASX shares and international shares, through both long-term investing and short-selling.

The ASX dividend share likes to invest in businesses with low price/earnings (P/E) ratios and still deliver good earnings growth. I think the investment team have shown a particular skill at investing at the right times in cyclical and commodity-based businesses.

Past performance is not a guarantee of future returns of course, but the L1 Long Short Fund portfolio return has helped it regularly increase its dividend over the last few years. The portfolio has returned an average of 17% per year over the last five years, though that’s not guaranteed to continue for the next five years.

It’s now paying a quarterly dividend and increasing that payment every quarter. I expect the next four quarterly dividends will come to a grossed-up dividend yield of 4.9%, including franking credits.

I highly rate these three ASX dividend shares and I expect to continue buying more shares over them in the coming years.

The post 3 of the best ASX dividend shares I own for passive income appeared first on The Motley Fool Australia.

More reading

• 2 ASX shares I plan to own until I’m 100
• 3 ASX shares I’d buy and hold for my kids
• Why I made this top ASX dividend share one of my biggest investments
• Where should I invest inside SMSFs instead of property?
• Want a pay rise? These ASX dividend shares keep delivering

Motley Fool contributor Tristan Harrison has positions in L1 Long Short Fund, Mff Capital Investments, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Mastercard, Visa, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Mff Capital Investments and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Alphabet, Amazon, Mastercard, and Visa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Karoon Energy Ltd (ASX: KAR) shares are getting some relief on Monday after a painful stretch for the ASX energy stock.

The Karoon share price is up 8.33% to $1.365 after the company updated investors on its Bauna operations in Brazil.

The bounce comes after a rough two weeks. Karoon shares have fallen more than 30% since the company lowered its CY26 production guidance earlier this month, which put pressure on investor confidence.

With Karoon’s market capitalisation sitting just under $1 billion, today’s update appears to have given investors something more positive to focus on.

Karoon restarts key Bauna well

According to the release, production has been restored from the SPS-92 well at Bauna after Karoon replaced its electrical submersible pump.

Karoon said SPS-92 is currently producing around 8,600 barrels of oil per day.

This means that Bauna production has now lifted to roughly 20,500 barrels per day before natural decline.

Karoon could get another lift from PRA-2 as well. Management expects that well to add around 1,000 to 2,000 barrels per day once it is brought back online, with umbilical work already underway.

SPS-92 has been causing problems since August last year, when a partial pump failure cut production by around 4,500 barrels per day.

While getting it back online doesn’t fix everything, it does ease some of the pressure on Karoon’s recent production outlook.

Higher production, higher costs

Karoon said the final cost of the SPS-92 intervention came in higher than first expected.

This was due to extra rig time, wellbore debris, and equipment-related downtime during the work.

As a result, the company has reviewed its 2026 investment expenditure guidance.

Bauna capex is now expected to be between US$89 million and US$97 million. This is up from the previous guidance range of US$61 million to US$74 million.

Total 2026 capex guidance has also increased to between US$178 million and US$202 million. Previously, Karoon was expecting US$150 million to US$183 million.

Management said the spending is expected to support the long-term value of Bauna and stronger operating cash flow in the second-half of 2026.

Can the rebound continue?

Karoon also gave investors another reason to take a second look.

The company announced that it plans to begin a further on-market share buyback from 1 July 2026.

This follows the recent completion of the second phase of its US$75 million buyback program, which was announced last year.

Management said the next phase will be carried out at a measured pace, with the company taking into account market conditions, capital requirements, and future growth projects.

The buyback should provide support after the recent sell-off, with Karoon saying its shares remain significantly undervalued at current levels.

The post Why this ASX energy stock is jumping 8% after a brutal sell-off appeared first on The Motley Fool Australia.

More reading

• 6 ASX shares with upgraded ratings from experts this week
• Buy, hold, sell: Karoon Energy, Brambles, REA shares
• Oil prices slump to pre-war levels as supply-risk premium evaporates
• 6 ASX shares upgraded by analysts this week
• Why Karoon Energy, Novonix, Transurban, and Woodside shares are sinking today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Life360 Inc (ASX: 360) shares are making a strong start to the week.

The ASX technology stock jumped 11% to $26.22 during Monday’s lunch-hour trade, extending an impressive recent rebound.

Life360 shares have now climbed around 35% over the past month. Even so, the stock remains well below its October peak and is still down roughly 16% over the past 12 months. By comparison, the S&P/ASX 200 Index (ASX: XJO) has gained about 3% over the same period.

So, what sparked today’s rally?

No major announcement, just improving sentiment

Interestingly, there has been no market-sensitive announcement from the company today. Instead, the buying appears to reflect growing confidence among investors and analysts that Life360’s underlying business is continuing to strengthen.

Life360 operates one of the world’s largest family safety platforms, offering location sharing, crash detection, emergency assistance, digital safety features, and device protection through a subscription-based model.

Its business continues to expand as more families join the platform and existing users upgrade to paid memberships.

Brokers are becoming more optimistic

Analyst sentiment around Life360 shares has steadily improved in recent months. TradingView data shows that 12 out of 13 analysts covering Life360 shares in the past three months rate it a buy or strong buy.

The average price target is $31.88, representing a potential 22% gain at current levels. The most bullish forecast sees a 53% upside, while the most pessimistic prediction sits around the current share price.

One reason for the improved sentiment is Life360’s continued growth in annualised recurring revenue (ARR), which gives investors greater visibility over future earnings.

Sustainable profitability, focus on AI

The company has also made significant progress towards sustainable profitability, easing concerns that high-growth technology companies must continually sacrifice earnings to expand.

Another positive is management’s growing focus on artificial intelligence, with AI expected to improve customer engagement, personalise features, and create additional monetisation opportunities over time.

Valuation is another factor. Following the heavy sell-off earlier this year, Life360 shares now trade on a price-to-earnings (P/E) ratio of roughly 27 times.

For a technology company still delivering strong subscriber growth, many investors see that multiple as increasingly attractive.

In other words, while the share price weakened sharply during the first half of 2026, the business itself continued moving in the opposite direction.

A rotation back into growth stocks?

There’s another possible explanation behind today’s move. Life360 shares were one of the hardest-hit ASX technology stocks during the first half of 2026 as investors rotated away from growth companies.

Now, that trend may be reversing. Stocks that have been heavily sold often rebound sharply when sentiment improves, particularly if the underlying business continues delivering strong operational results.

Whether today’s rally marks the beginning of a sustained recovery remains to be seen.

The post Life360 shares just jumped 11%. Here’s what’s driving the rally appeared first on The Motley Fool Australia.

More reading

• Why I think Life360 and Zip shares are strong buys
• Why this analyst rates Life360 shares a buy right now
• 5 ASX growth shares I want in my portfolio in FY27
• 3 reasons to buy the dip on Life360 shares today
• Buy, hold, sell: Life360, Woodside, CSL shares

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shares in Clarity Pharmaceuticals Ltd (ASX: CU6) were trading more than 10% higher in early trade on Monday after the company said it was going to present data from studies of its prostate cancer detection compound at an esteemed European medical conference.

But what was perhaps more compelling in the company’s announcement was a first person account from a patient who had used the company’s compound and had benefited greatly from it.

New detection methods being developed

Clarity has developed two radiopharmaceutical compounds called 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA which its studies to date show perform well compared with existing detection methods.

The company said it will present various data relating to the compounds at the European Association of Nuclear Medicine (EANM) Annual Congress 2026, which is being held in October in Vienna.

The biotechnology company said regarding the conference:

EANM 2026 Annual Congress is one of the world’s leading nuclear medicine conferences and the acceptance of these abstracts is testament to the strength of the data generated by Clarity’s products and the promising prospects for SAR-bisPSMA to change the paradigm in the diagnosis and treatment of prostate cancer.

The company said one of its trials which will be presented, “demonstrated improved diagnostic performance of 64Cu-SAR-bisPSMA next-day imaging vs. 68Ga-PSMA-11 across all key parameters assessed, including mean number of lesions per participant, total number of lesions, true positive rate and proportion of participants with a positive scan”.

The company will also present data from three client case studies, and said the use of its compound, “changed planned clinical management in all three patients”.

One of the patients, Steve Hunter, also supplied a testimonial.

Compelling first person account

Mr Hunter said he was diagnosed with prostate cancer in 2016, and while his initial treatment was quite successful, blood tests revealed in 2023 that his cancer had returned.

He said:

With SOC PSMA imaging currently available, no lesions were detectable. I was informed by more than one doctor that what I had was a micro-metastatic version of prostate cancer; that is, I had a large number of cancers too small to be detected.

Mr Hunter, himself a medical professional with a history including oncology research, approached Clarity with a view to trying its technology.

He said:

The results were beyond my expectations. Three tumours were found and I underwent targeted external beam radiation. Since then, I have repeated this process with Clarity and (Dr Alan Taylor’s) support a few times to scan, find and subsequently treat the ensuant small number of tumours that arise, with stereotactic radiation therapy. I am so grateful to Clarity in making these scans available. This approach has proven to be highly successful by allowing me to obtain clear information about my disease and defer requiring ADT therapy and all the associated side effects with this treatment.

Clarity shares were trading 14.1% higher at $2.07.  

The post Why is this ASX biotech charging more than 10% higher? appeared first on The Motley Fool Australia.

More reading

• This beaten-down ASX gold stock is jumping on a $300 million deal
• Forget term deposits! I’d buy these two ASX 300 shares instead
• Buy, hold, sell: Wildcat Resources, NAB, Wisetech shares
• Which ASX ETF will pay an eye-popping $18 per share dividend this season?
• What are ASX 200 futures?

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Monday has finally brought some relief for Ramelius Resources Ltd (ASX: RMS) shareholders.

After a rough start to 2026, the ASX gold stock is climbing after announcing a $300 million deal to sell its Edna May Gold Hub in Western Australia.

At the time of writing, the Ramelius share price is up 3.81% to $3.00 apiece. By comparison, the S&P/ASX 200 Index(ASX: XJO) is up 0.1% to 8,775 points.

That still leaves the stock down around 28% since the start of the year, although it remains 20% higher over the past 12 months.

Let’s take a closer look at the deal.

Ramelius sells Edna May

According to the release, Ramelius has entered into a binding agreement to sell the Edna May Gold Hub to Forrestania Resources Ltd (ASX: FRS).

Forrestania shares last traded at 42.5 cents before the company was placed in a trading halt.

The deal is worth $300 million upfront, made up of $200 million in cash and $100 million in Forrestania shares.

Ramelius has already received a $20 million deposit, with the rest of the cash and shares payable once the transaction is completed.

Edna May has been part of Ramelius since 2017, when it was acquired from Evolution Mining Ltd (ASX: EVN). Since then, the operation has produced around 760,000 ounces of gold.

However, the mine is not currently producing. It has been on care and maintenance duties from April 2025.

Ramelius managing director Mark Zeptner described the sale as “a logical transaction” for both companies.

Why buyers are returning today

The positive share price reaction suggests investors are happy to see Ramelius unlock value from Edna May.

The company is receiving a sizeable cash payment from an asset that is no longer producing. It also keeps some exposure to Edna May through its Forrestania shareholding.

That could be very useful if Forrestania can get the processing plant running again and build a larger regional gold business around the asset.

Ramelius said it is now focused on the transformation of its Mt Magnet operations and the development of Rebecca-Roe.

What happens next

Although the sale appears to be moving forward, keep in mind that the deal isn’t done just yet.

Forrestania still needs to secure at least $200 million in binding commitments under its proposed equity raising.

And on top of that, its shareholders also need to approve the issue of shares under the agreement.

If those conditions are met, Ramelius expects the transaction to complete in the September quarter of 2026.

The post This beaten-down ASX gold stock is jumping on a $300 million deal appeared first on The Motley Fool Australia.

More reading

• This ASX gold company’s aggressive M&A program continues with $300 million deal
• 5 ASX 200 gold stocks to buy and hold amid the crashing gold price
• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX 200 shares today
• 6 ASX shares upgraded by analysts this week

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.